1. Home
  2. CIEN vs HALO Comparison

CIEN vs HALO Comparison

Compare CIEN & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CIEN
  • HALO
  • Stock Information
  • Founded
  • CIEN 1992
  • HALO 1998
  • Country
  • CIEN United States
  • HALO United States
  • Employees
  • CIEN N/A
  • HALO N/A
  • Industry
  • CIEN Telecommunications Equipment
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • CIEN Utilities
  • HALO Health Care
  • Exchange
  • CIEN Nasdaq
  • HALO Nasdaq
  • Market Cap
  • CIEN 8.4B
  • HALO 7.4B
  • IPO Year
  • CIEN 1997
  • HALO N/A
  • Fundamental
  • Price
  • CIEN $79.56
  • HALO $48.99
  • Analyst Decision
  • CIEN Buy
  • HALO Buy
  • Analyst Count
  • CIEN 13
  • HALO 9
  • Target Price
  • CIEN $78.62
  • HALO $63.78
  • AVG Volume (30 Days)
  • CIEN 1.5M
  • HALO 2.6M
  • Earning Date
  • CIEN 06-05-2025
  • HALO 05-06-2025
  • Dividend Yield
  • CIEN N/A
  • HALO N/A
  • EPS Growth
  • CIEN N/A
  • HALO 55.40
  • EPS
  • CIEN 0.55
  • HALO 3.76
  • Revenue
  • CIEN $4,049,506,000.00
  • HALO $1,084,306,000.00
  • Revenue This Year
  • CIEN $12.65
  • HALO $24.79
  • Revenue Next Year
  • CIEN $8.89
  • HALO $22.65
  • P/E Ratio
  • CIEN $146.59
  • HALO $13.36
  • Revenue Growth
  • CIEN N/A
  • HALO 25.64
  • 52 Week Low
  • CIEN $44.69
  • HALO $41.28
  • 52 Week High
  • CIEN $101.44
  • HALO $70.51
  • Technical
  • Relative Strength Index (RSI)
  • CIEN 72.35
  • HALO 33.26
  • Support Level
  • CIEN $70.67
  • HALO $48.10
  • Resistance Level
  • CIEN $73.93
  • HALO $69.94
  • Average True Range (ATR)
  • CIEN 2.26
  • HALO 3.31
  • MACD
  • CIEN 1.42
  • HALO -1.04
  • Stochastic Oscillator
  • CIEN 89.02
  • HALO 3.96

About CIEN Ciena Corporation

Ciena Corp is a network and technology company. It provides network hardware, software, and services that support the transport, switching, aggregation, service delivery, and management of video, data, and voice traffic on communications networks. It serves various industries such as communication services providers, web-scale providers, cable operators, government, and large enterprises world-wide. The business activities function through Networking Platforms which generates maximum revenue; Platform Software and Services; Blue Planet Automation Software, and Global Services segments. Geographically, the company derives a majority of its revenue from the Americas, and the rest from the Asia-Pacific (APAC), and Europe, Middle East, and Africa (EMEA) region.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: